Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Pharmaceutical Distribution in Europe: The Emergence of Direct-to-Pharmacy Supply

352 views

Published on

"Each day millions of patients across Europe rely on the supply chain to deliver the medicines they need" Pharmaceutical Distribution in Europe - The Emergence of Direct-to-Pharmacy Supply from URCH Publishing, is a market report that comprehensively reviews the business of medicines distribution in Europe. The traditional model of pharmaceutical supply chain in Europe is under threat as major pharmaceutical manufacturers in the UK attempt to change the way they distribute their products. The adoption of a Direct-to-pharmacy (DTP) model by some of the industry's most powerful players in the UK signifies a new trend that could spread across Europe. REPORT STRUCTURE The report is logically divided into four chapters. Chapter 1 provides a comprehensive history and overview of the key issues related to the pharmaceutical supply chain in Europe, including European law, parallel trade and the recent EU enlargement. Chapter 2 fully reviews the role of pharmaceutical wholesale companies. Issues tackled include regulations, technologies used, plus reviews of the major players such as Celesio, Phoenix Group and OPG and the market in France, Germany, Italy and the UK. Chapter 3 discusses how pharmaceutical manufacturers organise the distribution of their products. The current vogue for direct-to-pharmacy is analysed, as is reaction to the UK's OFT report. Recent changes by major manufacturers to their supply chain are summarised. Chapter 4 looks at the pressures that the pharmacy sector is under. Liberalisation still in its infancy in some countries and pharmacists are being encouraged to expand their role beyond just dispensing. Changes to the supply chain could have a profound effect on established business models. The report provides an objective perspective on important industry questions, such as; Will direct-to-pharmacy become the dominant method of drug distribution Do pharmacists have a future beyond the administration of dispensing' Are counterfeit medicines now a major issues that the industry has to deal with' What is the current thinking on the role of parallel trade in the European market' Key features of the report include: Contains 20 Case studies including these companies, Bayer, DocMorris, Galencia, IBS, Novartis, Phoenix and Pfizer, Unbiased synopsis of the UK's Office of Fair Trading's (OFT) report into the medicines' supply chain Overview of the European pharmaceutical supply chain and the stakeholders involved in medicines distribution Insight into the aggressive Pan-European expansion strategies of some wholesalers Summary of regulations governing pharmaceutical wholesaling and pharmacy With 14 Tables and 26 Figures this report is essential reading for anyone working in the pharmaceuticals supply chain including manufacturers, wholesalers, distributors and pharmacists. Companies and organisations mentioned in the report include: 3i, Alliance Unichem, Amedis UE AG, Apteka, Associazione Distributori Farmaceutici, Astellas Pharma, AstraZeneca, Authentix, Azienda Speciale Farmacie Comunali Riunite, Bayer, British Association of Pharmaceutical Wholesalers, Celesio AG, Chambre Syndicale de la Rpartition Pharmaceutique, Chiron, Dainippon Sumitomo Pharma, Der Bundesverband des pharmazeutischen Grohandels, DocMorris, EAEPC, Eli Lilly, Europharm, Farmaceutica Bolognese, Farmacija d.d, FDA, Galenica Group, Galexis, GEHE Pharma Handel, Groupement International de la Rpartition Pharmaceutique, HgCapita, Independent Pharmacy Federation, International Pharmaceutical Excipients Council, Itriafarma, Mediceo Paltac Holdings, Medifarm Velebit, MediService, Merck, Neuhaus Partners, Norsk Medisinaldepot, Novartis, OPG Group, Pfizer, Pharmexx, PhRMA, PHOENIX group, Plus Pharmacie, Retail Working Group, Sanofi-Aventis, Surgency, Syncra Systems, Takeda, Tamro, Unione Farmaceutica, Viafarma, Voigt AG USE THIS REPORT TO: Identify key areas that will change in the pharmaceutical market structure over t

  • //DOWNLOAD THIS BOOKS INTO AVAILABLE FORMAT ......................................................................................................................... ......................................................................................................................... //DOWNLOAD PDF EBOOK here { https://tinyurl.com/y8nn3gmc } ......................................................................................................................... //DOWNLOAD EPUB Ebook here { https://tinyurl.com/y8nn3gmc } ......................................................................................................................... //DOWNLOAD doc Ebook here { https://tinyurl.com/y8nn3gmc } ......................................................................................................................... //DOWNLOAD PDF EBOOK here { https://tinyurl.com/y8nn3gmc } ......................................................................................................................... //DOWNLOAD EPUB Ebook here { https://tinyurl.com/y8nn3gmc } ......................................................................................................................... //DOWNLOAD doc Ebook here { https://tinyurl.com/y8nn3gmc } ......................................................................................................................... ......................................................................................................................... ......................................................................................................................... .............. Browse by Genre Available eBooks ......................................................................................................................... Art, Biography, Business, Chick Lit, Children's, Christian, Classics, Comics, Contemporary, Cookbooks, Crime, Ebooks, Fantasy, Fiction, Graphic Novels, Historical Fiction, History, Horror, Humor And Comedy, Manga, Memoir, Music, Mystery, Non Fiction, Paranormal, Philosophy, Poetry, Psychology, Religion, Romance, Science, Science Fiction, Self Help, Suspense, Spirituality, Sports, Thriller, Travel, Young Adult,
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • Be the first to like this

Pharmaceutical Distribution in Europe: The Emergence of Direct-to-Pharmacy Supply

  1. 1. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Pharmaceutical Distribution in Europe: The Emergence ofDirect-to-Pharmacy SupplyPublished on February 2008 Report Summary"Each day millions of patients across Europe rely on the supply chain to deliver the medicines they need"Pharmaceutical Distribution in Europe - The Emergence of Direct-to-Pharmacy Supply from URCH Publishing, is a market reportthat comprehensively reviews the business of medicines distribution in Europe.The traditional model of pharmaceutical supply chain in Europe is under threat as major pharmaceutical manufacturers in the UKattempt to change the way they distribute their products. The adoption of a Direct-to-pharmacy (DTP) model by some of the industrysmost powerful players in the UK signifies a new trend that could spread across Europe.REPORT STRUCTUREThe report is logically divided into four chapters.Chapter 1 provides a comprehensive history and overview of the key issues related to the pharmaceutical supply chain in Europe,including European law, parallel trade and the recent EU enlargement.Chapter 2 fully reviews the role of pharmaceutical wholesale companies. Issues tackled include regulations, technologies used, plusreviews of the major players such as Celesio, Phoenix Group and OPG and the market in France, Germany, Italy and the UK.Chapter 3 discusses how pharmaceutical manufacturers organise the distribution of their products. The current vogue fordirect-to-pharmacy is analysed, as is reaction to the UKs OFT report. Recent changes by major manufacturers to their supply chainare summarised.Pharmaceutical Distribution in Europe: The Emergence of Direct-to-Pharmacy Supply (From Slideshare) Page 1/12
  2. 2. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Chapter 4 looks at the pressures that the pharmacy sector is under. Liberalisation still in its infancy in some countries andpharmacists are being encouraged to expand their role beyond just dispensing. Changes to the supply chain could have a profoundeffect on established business models.The report provides an objective perspective on important industry questions, such as;Will direct-to-pharmacy become the dominant method of drug distributionDo pharmacists have a future beyond the administration of dispensingAre counterfeit medicines now a major issues that the industry has to deal withWhat is the current thinking on the role of parallel trade in the European marketKey features of the report include:Contains 20 Case studies including these companies, Bayer, DocMorris, Galencia, IBS, Novartis, Phoenix and Pfizer,Unbiased synopsis of the UKs Office of Fair Tradings (OFT) report into the medicines supply chainOverview of the European pharmaceutical supply chain and the stakeholders involved in medicines distributionInsight into the aggressive Pan-European expansion strategies of some wholesalersSummary of regulations governing pharmaceutical wholesaling and pharmacyWith 14 Tables and 26 Figures this report is essential reading for anyone working in the pharmaceuticals supply chain includingmanufacturers, wholesalers, distributors and pharmacists.Companies and organisations mentioned in the report include:3i, Alliance Unichem, Amedis UE AG, Apteka, Associazione Distributori Farmaceutici, Astellas Pharma, AstraZeneca, Authentix,Azienda Speciale Farmacie Comunali Riunite, Bayer, British Association of Pharmaceutical Wholesalers, Celesio AG, ChambreSyndicale de la Rpartition Pharmaceutique, Chiron, Dainippon Sumitomo Pharma, Der Bundesverband des pharmazeutischenGrohandels, DocMorris, EAEPC, Eli Lilly, Europharm, Farmaceutica Bolognese, Farmacija d.d, FDA, Galenica Group, Galexis, GEHEPharma Handel, Groupement International de la Rpartition Pharmaceutique, HgCapita, Independent Pharmacy Federation,International Pharmaceutical Excipients Council, Itriafarma, Mediceo Paltac Holdings, Medifarm Velebit, MediService, Merck,Neuhaus Partners, Norsk Medisinaldepot, Novartis, OPG Group, Pfizer, Pharmexx, PhRMA, PHOENIX group, Plus Pharmacie, RetailWorking Group, Sanofi-Aventis, Surgency, Syncra Systems, Takeda, Tamro, Unione Farmaceutica, Viafarma, Voigt AGUSE THIS REPORT TO:Identify key areas that will change in the pharmaceutical market structure over the next five years.Support internal planning and decision-making with an external perspective founded on detailed analysis and transparent marketforecasts.Understand how the regulatory environment could change to reflect new business models.Pharmaceutical Distribution in Europe: The Emergence of Direct-to-Pharmacy Supply (From Slideshare) Page 2/12
  3. 3. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Remember URCH Publishings healthcare management reports are designed to help business executives make properly informedand timely business decisions. Table of ContentExecutive SummaryChapter 1: The Nature of the European Pharmaceutical Supply ChainThe pharmaceutical supply chainPharmaceutical manufacturers in the EUPharmacies in the EUWholesalers in the EUThe hospital sectorPrewholesalingHistory of the pharmaceutical supply chainDynamics in the supply changeRelationships within the supply chainVertical integrationNew changes in the supply changeOutlook for the supply chainGlobal lessons for the supply chainCase study: Consolidation among Japanese pharmaceutical wholesalersEuropean status of the supply chainStability of the European supply chainProduct shortages in the supply chainCase study: Vaccine shortages and the effect on the supply chainCase study: Supply chain disruption in Latin AmericaTraceability throughout the supply chainCounterfeit productsInternet trading and pharmaceuticalsParallel tradeThe view of pharmaceutical manufacturersPharmaceutical Distribution in Europe: The Emergence of Direct-to-Pharmacy Supply (From Slideshare) Page 3/12
  4. 4. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!The view of parallel importersLegalities of parallel tradeExhaustion of intellectual property rightsRepackaging and relabelling of productsConsumer views of intellectual property rightsThe European UnionHistory of the EUThe set-up of the EUEU lawPrimary legislationSecondary legislationCase-lawDecision-making in the EUThe institutions of the EUThe European Economic Area (EEA)The creation of the EEAEU Enlargement and the EEAThe EuroThe Euro and pharmaceuticalsChapter 2: Challenges for medicine wholesalers in EuropeThe role of the pharmaceutical wholesalerChannels of distributionWholsalers and the Single European marketWholesaler opposition to supply quotasCase study: Bayers Export Policy for AdalatCase study: Syfait versus GlaxoSmithKlinePharmaceutical Distribution in Europe: The Emergence of Direct-to-Pharmacy Supply (From Slideshare) Page 4/12
  5. 5. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Wholesaler views of Direct-to-Phamacy distributionCrossborder mergers and acquisitionsCase study: Double acquisition by Phoenix ensures successful market entry into CroatiaEU harmonisation and the outlook for pan-European wholesaleingThe major players in pan-European wholesaleingCelesio AGThe PHOENIX GroupOPG GroupAlliance BootsEuropean regulations for wholesalersGuidelines on Good Distribution Practice of Medicinal Products for Human Use (94/C 63/03)Lack of harmonisation and the supply chainWholesaler technology solutionsElectronic data interchangeCollaborative planning forecasting and replenishmentEnterprise resource planningWholesalers develop value added servicesCase study: GEHE Pharma Handel chosen as "Best-Practice-Enterprise" for value added servicesCase study: PHOENIX wins pharmacy partner awardOrder fulfilment packagesDatabase technologyElectronic point-of-sale technologyBar codingCase study: US highlights benefits of bar code and RFID technologiesCase study: Pfizer France reviews the RFID system for ViagraCase study: AstraZeneca opts for mass serialisation to prevent counterfeitingEuropean wholesaler opinions on technological solutionsWarehouse technologyDispensing technologyTechology in the future of pharma distributionConsumers and e-commercePharmaceutical Distribution in Europe: The Emergence of Direct-to-Pharmacy Supply (From Slideshare) Page 5/12
  6. 6. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Case study: DocMorrisPharmaceutical distribution in UKPharmaceutical distribution in FranceCase study: Industry support of the Masters Degree in Pharmaceutical Distribution at University of LimogesPharmaceutical distribution in GermanyPharmaceutical distribution in ItalyCase study: IBS introduces supply chain management solutions into the Italian pharmaceutical marketPharmaceutical distribution in SpainPharmaceutical distribution in SwitzerlandCase study: Galenica expands its service offeringsChapter 3: Manufacturers start to control the ditribution of pharmaceuticalsPharmaceutical manufacturers in EuropeThe pharmaceutical industry and the supply chainThe role of pharmaceuticalsDrug development and innovationCost containmentThe pharmaceutical marketLack of harmonisation in the EU pharmaceutical marketCounterfeitingPharmaceutical Distribution in Europe: The Emergence of Direct-to-Pharmacy Supply (From Slideshare) Page 6/12
  7. 7. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Pharmaceutical industry efforts to combat counterfeitingManufacturers exert control over the supply chainThe Office of Fair Trading investigationImplications of changes in the supply chainService standards to patientsRationale behind changes in the supply chainPfizers feedback on Direct-to-Pharmacy distributionCase study: Pfizer UKs Direct-to-Pharmacy websiteReaction to the Office of Fair Trading enquiryAstraZeneca changes its supply chain arrangementsSanofi-Aventis changes its supply chain arrangementsNapp Pharmaceuticals changes its supply chain arrangementsNovartis considers changes to supply chain arrangementsEli Lilly considers changes to supply chain arrangementsAstellas adopts direct distribution for Transplant MedicinesPatients and healthcareCase study: The International Alliance of Patients OrganizationsPharmaceutical manufacturers and the developing countriesCollaborations with healthcare providersCase study: Novartis makes agreement with the World Health Organization for distribution of malaria treatmentCase study: Diversion of anti-retroviral drugs destined for AfricaAnti-diversion tacticsChapter 4: Pharmacy and the Future of Medicines DistributionPharmacies in EuropePharmaceutical Distribution in Europe: The Emergence of Direct-to-Pharmacy Supply (From Slideshare) Page 7/12
  8. 8. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Additional pharmacy servicesDifferences in pharmacy regulationsHospital pharmacy in EuropeWholesaler Margins and VATRebates and discountsDistribution of OTCsGenericsIndependent pharmaciesPharmacy chainsWholesaler involvement in pharmacy chainsPharmacy purchasing groupsSupermarketsDrugstore chainsMail-order pharmacyRemoving restrictions in the European pharmacy sectorCase study: European Commission challenges Italian legislation concerning pharmaciesCase study: European Commission challenges Spanish legislation concerning pharmaciesCase study: European Commission challenges Austrian legislation concerning pharmaciesSale of non-prescription products outside pharmaciesImplications of liberalisation in the European pharmacy sectorLiberalisation of the pharmacy sector and accessibilityLiberalisation of the pharmacy sector and market dominanceLiberalisation of the pharmacy sector and quality of servicePharmacies and changes in the supply chainPharmaceutical Distribution in Europe: The Emergence of Direct-to-Pharmacy Supply (From Slideshare) Page 8/12
  9. 9. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!REFERENCESList of FiguresFigure 1.1 Outline of the Supply ChainFigure 1.2 Number of pharmacists (per 1000 population)Figure 1.3 Total revenue of European pharmaceutical wholesalers (without VAT)Figure 1.4 Worldwide Vaccine MarketFigure 1.5 Share of parallel imports in European pharmacy marketsFigure 2.1 Number of Full-line WholesalersFigure 2.2 Average gross margin of wholesalers in 9 West Europe CountriesFigure 2.3 Celesio AG Wholesale Revenue by Market (2006)Figure 2.4 Celesio AG Pharmacy Revenue by Market (2006)Figure 2.5 Phoenix Group Turnover (2002 - 2007)Figure 2.6 Breakdown of OPG Sales (2006)Figure 2.7 Alliance Boots Wholesale Division Revenue (Q1,2,3 2006)Figure 2.8 Percentage of electronic orders from pharmacies to wholesalersFigure 3.1 Pharmaceutical R&D Expenditure in Europe 1195 - 2006Figure 3.2 Pharmaceutical R&D Expenditure across EuropeFigure 3.3 NHS expenditure per person in the UKFigure 3.4 Community prescribing in the UK: Prescriptions Per headFigure 3.5 Patient satisfaction with quality and effectiveness of healthcare receivedFigure 3.6 Patient satisfaction with ability to access information on new medicines or treatmentsFigure 4.1 Number of Public Pharmacies (12 European Countries)Figure 4.2 Pharmacy sales per inhabitant Europe (€)Figure 4.3 Number of Hospital Pharmacies in 8 CountriesFigure 4.4 VAT rates applied to prescription medicines across EuropeFigure 4.5 Share of generics in European pharmaceutical marketsFigure 4.6 Percent change in number of pharmacies N, E, N, A, F, S(1995 - 2005)Figure 4.7 UK Pharmacy respondent views on potential costs of setting up a separate Pfizer account for DTPList of TablesTable 1.1: Types of manufacturer medicinesTable 1.2: The institutions of the EUTable 1.3: Adoption of the euroTable 2.1: OPGs activities in EuropeTable 2.2: Summary of GDP GuidelinesTable 2.3: The BAPWs Gold Standard of Good Distribution Practice by Pharmaceutical Wholesalers as endorsed by the MHRATable 2.4: Process of adoption of IBS supply chain management solution by ItriafarmaTable 3.1 Key areas of focus for the International Medicinal Products Anti-Counterfeiting Taskforce (IMPACT)Table 3.2: Overall risks due to DTP identified by OFTPharmaceutical Distribution in Europe: The Emergence of Direct-to-Pharmacy Supply (From Slideshare) Page 9/12
  10. 10. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Table 3.3: Implications of reduced service standards due to DTP (adapted from OFT, 2007)Table 3.4: Anti-diversion tactics employed by pharmaceutical manufacturers and cited by WHOTable 4.1: Goals of the EAHPTable 4.2: Summary of liberalised pharmacy sector in "case study" countries chosen by BIGTable 4.3: Summary of regulated pharmacy sector in "reference study" countries chosen by BIGPharmaceutical Distribution in Europe: The Emergence of Direct-to-Pharmacy Supply (From Slideshare) Page 10/12
  11. 11. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. Pharmaceutical Distribution in Europe: The Emergence of Direct-to-Pharmacy Supply Product Formats Please select the product formats and the quantity you require. 1 User License--USD 1 509.38 Quantity: _____ Corporate License--USD 12 336.36 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________Pharmaceutical Distribution in Europe: The Emergence of Direct-to-Pharmacy Supply (From Slideshare) Page 11/12
  12. 12. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93Pharmaceutical Distribution in Europe: The Emergence of Direct-to-Pharmacy Supply (From Slideshare) Page 12/12

×